Goals include expanded patient access to underserved populations, faster results, and reduced provider burden COLUMBUS, Ohio, Oct. 6, 2023 /PRNewswire/ — Paradigm announced today a collaboration with Bristol Myers Squibb (NYSE: BMY) to build a new end-to-end clinical trial operating…